{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:31:03Z","timestamp":1788535863940,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.prp.2024.155667","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:29:33Z","timestamp":1729643373000},"page":"155667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Delivery of doxorubicin by Fe3O4 nanoparticles, reduces multidrug resistance gene expression in ovarian cancer cells"],"prefix":"10.1016","volume":"263","author":[{"given":"Roghiyeh","family":"Pashaei-Asl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Motaali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Ebrahimie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manijeh","family":"Mohammadi-Dehcheshmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Pashaiasl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155667_bib1","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.prp.2024.155667_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.prp.2024.155667_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","article-title":"Focus on epithelial ovarian cancer","volume":"5","author":"Ozols","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2024.155667_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5\u2014a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155667_bib5","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.prp.2024.155667_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1757-2215-2-21","article-title":"Mucins in ovarian cancer diagnosis and therapy","volume":"2","author":"Chauhan","year":"2009","journal-title":"J. ovarian Res."},{"key":"10.1016\/j.prp.2024.155667_bib7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2024.155667_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2019.100645","article-title":"The multi-factorial nature of clinical multidrug resistance in cancer","volume":"46","author":"Assaraf","year":"2019","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.prp.2024.155667_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4161\/cbt.26609","article-title":"Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models","volume":"15","author":"Apte","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2024.155667_bib10","first-page":"549","article-title":"ABC transporter-mediated multidrug-resistant cancer","author":"Amawi","year":"2019","journal-title":"Drug Transp. Drug Dispos., Eff. Toxic."},{"key":"10.1016\/j.prp.2024.155667_bib11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0021-9258(19)40260-3","article-title":"Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins","volume":"265","author":"Chen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2024.155667_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.prp.2024.155667_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00280-017-3365-y","article-title":"Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1)","volume":"80","author":"Yan","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.prp.2024.155667_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.prp.2024.155667_bib15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jog.14558","article-title":"Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabine","volume":"47","author":"Takahashi","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.prp.2024.155667_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1271420","article-title":"Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer","volume":"11","author":"Zeng","year":"2023","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.prp.2024.155667_bib17","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.2147\/IJN.S388075","article-title":"Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer","volume":"17","author":"Liu","year":"2022","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.prp.2024.155667_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120117","article-title":"Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization","volume":"593","author":"Makwana","year":"2021","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.prp.2024.155667_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.15171\/apb.2017.022","article-title":"Legionella Pneumophila and Dendrimers-Mediated Antisense Therapy","volume":"7","author":"Pashaei-Asl","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.prp.2024.155667_bib20","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s13346-023-01368-x","article-title":"Combination of micelles and liposomes as a promising drug delivery system: a review","volume":"13","author":"Qian","year":"2023","journal-title":"Drug Deliv. Transl. Res"},{"key":"10.1016\/j.prp.2024.155667_bib21","article-title":"Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.prp.2024.155667_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122575","article-title":"Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations","volume":"632","author":"Scialla","year":"2023","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.prp.2024.155667_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.prp.2024.155667_bib24","article-title":"Engineered nanocarriers of doxorubicin: a current update. Critical Reviews\u2122","volume":"25","author":"Patil","year":"2008","journal-title":"Ther. Drug Carr. Syst."},{"key":"10.1016\/j.prp.2024.155667_bib25","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ad1dfe","article-title":"Synthesis of Fe(3)O(4)core\/MIL-100(Fe) shell nanocomposites for tumor chemo-ferroptosis combination therapy and MR imaging","volume":"19","author":"Jiang","year":"2024","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.prp.2024.155667_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4155\/fmc.09.164","article-title":"Magnetic iron oxide nanoparticles for biomedical applications","volume":"2","author":"Laurent","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.prp.2024.155667_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/910539","article-title":"Smart magnetically responsive hydrogel nanoparticles prepared by a novel aerosol-assisted method for biomedical and drug delivery applications","volume":"2011","author":"El-Sherbiny","year":"2011","journal-title":"J. Nanomater."},{"key":"10.1016\/j.prp.2024.155667_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2013.02.042","article-title":"Dual anticancer drug\/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging","volume":"447","author":"Schleich","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.prp.2024.155667_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-3659(96)01614-8","article-title":"Acrylic type polymers containing ibuprofen and indomethacin with difunctional spacer group: synthesis and hydrolysis","volume":"47","author":"Davaran","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.prp.2024.155667_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.apsusc.2014.09.092","article-title":"Doxorubicin poly N-vinylpyrrolidone and poly N-isopropylacrylamide-co-N-vinylpyrrolidone coated magnetic nanoparticles","volume":"320","author":"Habibi","year":"2014","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.prp.2024.155667_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nantod.2016.02.004","article-title":"Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery","volume":"11","author":"Habibi","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.prp.2024.155667_bib32","first-page":"5197","article-title":"Multifunctionalization of graphene and graphene oxide for controlled release and targeted delivery of anticancer drugs","volume":"9","author":"Liu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2024.155667_bib33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fchem.2018.00619","article-title":"Magnetic drug delivery: Where the field is going","volume":"6","author":"Price","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.prp.2024.155667_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-015-0576-1","article-title":"Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery","volume":"17","author":"Kossatz","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2024.155667_bib35","first-page":"738","article-title":"Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment","volume":"7","author":"Wu","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155667_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcis.2014.07.013","article-title":"Synthesis, characterization, and cellular uptake of magnetic nanocarriers for cancer drug delivery","volume":"433","author":"Momtazi","year":"2014","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.prp.2024.155667_bib37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3109\/21691401.2016.1161640","article-title":"Synthesis and characterization of smart N-isopropylacrylamide-based magnetic nanocomposites containing doxorubicin anti-cancer drug","volume":"45","author":"Motaali","year":"2017","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"key":"10.1016\/j.prp.2024.155667_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15171\/apb.2017.029","article-title":"The inhibitory effect of ginger extract on ovarian cancer cell line; application of systems biology","volume":"7","author":"Pashaei-Asl","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.prp.2024.155667_bib39","first-page":"191","article-title":"Apoptotic effects of human amniotic fluid mesenchymal stem cells conditioned medium on human MCF-7 breast cancer cell line","volume":"13","author":"Pashaei-Asl","year":"2023","journal-title":"BioImpacts: BI"},{"key":"10.1016\/j.prp.2024.155667_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.gene.2015.12.023","article-title":"Unravelling evolution of Nanog, the key transcription factor involved in self-renewal of undifferentiated embryonic stem cells, by pattern recognition in nucleotide and tandem repeats characteristics","volume":"578","author":"Pashaiasl","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.prp.2024.155667_bib41","article-title":"The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line","volume":"7","author":"Gholizadeh-Ghaleh Aziz","year":"2019","journal-title":"Mol. Genet Genom. Med"},{"key":"10.1016\/j.prp.2024.155667_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020319","article-title":"A Transcription Regulatory Sequence in the 5\u2032 Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs","volume":"10","author":"Mohammadi-Dehcheshmeh","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.prp.2024.155667_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061758","article-title":"Synthesis, Characterization, and In Vitro Cytotoxicity Evaluation of Doxorubicin-Loaded Magnetite Nanoparticles on Triple-Negative Breast Cancer Cell Lines","volume":"15","author":"Markhulia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2024.155667_bib44","article-title":"Prolonged Local In Vivo Delivery of Stimuli-Responsive Nanogels That Rapidly Release Doxorubicin in Triple-Negative Breast Cancer Cells","volume":"9","author":"Zhang","year":"2020","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.prp.2024.155667_bib45","first-page":"2199","article-title":"Induction of MDR1-gene expression by antineoplastic agents in ovarian cancer cell lines","volume":"22","author":"Sch\u00f6ndorf","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prp.2024.155667_bib46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/0008-5472.CAN-11-2890","article-title":"Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells","volume":"72","author":"Arora","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2024.155667_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246246","article-title":"Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets","volume":"14","author":"Alatise","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824005788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824005788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T03:55:25Z","timestamp":1732334125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824005788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":47,"alternative-id":["S0344033824005788"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155667","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of doxorubicin by Fe3O4 nanoparticles, reduces multidrug resistance gene expression in ovarian cancer cells","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155667"}}